These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17174885)

  • 41. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator.
    Li X; Monks B; Ge Q; Birnbaum MJ
    Nature; 2007 Jun; 447(7147):1012-6. PubMed ID: 17554339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sirtuins regulate key aspects of lipid metabolism.
    Lomb DJ; Laurent G; Haigis MC
    Biochim Biophys Acta; 2010 Aug; 1804(8):1652-7. PubMed ID: 19962456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha.
    Lerin C; Rodgers JT; Kalume DE; Kim SH; Pandey A; Puigserver P
    Cell Metab; 2006 Jun; 3(6):429-38. PubMed ID: 16753578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resveratrol-activated SIRT1 in liver and pancreatic β-cells: a Janus head looking to the same direction of metabolic homeostasis.
    Vetterli L; Maechler P
    Aging (Albany NY); 2011 Apr; 3(4):444-9. PubMed ID: 21483037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1).
    van der Horst A; Tertoolen LG; de Vries-Smits LM; Frye RA; Medema RH; Burgering BM
    J Biol Chem; 2004 Jul; 279(28):28873-9. PubMed ID: 15126506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases.
    Knutson MD; Leeuwenburgh C
    Nutr Rev; 2008 Oct; 66(10):591-6. PubMed ID: 18826454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic effects of resveratrol in mammals--a link between improved insulin action and aging.
    Fröjdö S; Durand C; Pirola L
    Curr Aging Sci; 2008 Dec; 1(3):145-51. PubMed ID: 20021385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of hyperglycemia and aging on nuclear sirtuins and DNA damage of mouse hepatocytes.
    Ghiraldini FG; Crispim AC; Mello ML
    Mol Biol Cell; 2013 Aug; 24(15):2467-76. PubMed ID: 23761075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain.
    Shin JA; Lee KE; Kim HS; Park EM
    Neurochem Res; 2012 Dec; 37(12):2686-96. PubMed ID: 22878646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells.
    Miyazaki R; Ichiki T; Hashimoto T; Inanaga K; Imayama I; Sadoshima J; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1263-9. PubMed ID: 18420994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+).
    Gerhart-Hines Z; Dominy JE; Blättler SM; Jedrychowski MP; Banks AS; Lim JH; Chim H; Gygi SP; Puigserver P
    Mol Cell; 2011 Dec; 44(6):851-63. PubMed ID: 22195961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SIRT1 and endocrine signaling.
    Yang T; Fu M; Pestell R; Sauve AA
    Trends Endocrinol Metab; 2006 Jul; 17(5):186-91. PubMed ID: 16684606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo.
    Smith JJ; Kenney RD; Gagne DJ; Frushour BP; Ladd W; Galonek HL; Israelian K; Song J; Razvadauskaite G; Lynch AV; Carney DP; Johnson RJ; Lavu S; Iffland A; Elliott PJ; Lambert PD; Elliston KO; Jirousek MR; Milne JC; Boss O
    BMC Syst Biol; 2009 Mar; 3():31. PubMed ID: 19284563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AROuSing SIRT1: identification of a novel endogenous SIRT1 activator.
    Verdin E
    Mol Cell; 2007 Nov; 28(3):354-6. PubMed ID: 17996699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CAT in the HAT: catabolic inhibition by the histone acetyltransferase GCN5.
    Liu Y; Montminy M
    Cell Metab; 2006 Jun; 3(6):387-8. PubMed ID: 16753572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical effects of SIRT1 activators.
    Baur JA
    Biochim Biophys Acta; 2010 Aug; 1804(8):1626-34. PubMed ID: 19897059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Free [NADH]/[NAD(+)] regulates sirtuin expression.
    Gambini J; Gomez-Cabrera MC; Borras C; Valles SL; Lopez-Grueso R; Martinez-Bello VE; Herranz D; Pallardo FV; Tresguerres JA; Serrano M; Viña J
    Arch Biochem Biophys; 2011 Aug; 512(1):24-9. PubMed ID: 21575591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SirT1 gain of function increases energy efficiency and prevents diabetes in mice.
    Banks AS; Kon N; Knight C; Matsumoto M; Gutiérrez-Juárez R; Rossetti L; Gu W; Accili D
    Cell Metab; 2008 Oct; 8(4):333-41. PubMed ID: 18840364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity.
    Satoh A; Stein L; Imai S
    Handb Exp Pharmacol; 2011; 206():125-62. PubMed ID: 21879449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan.
    Fernández AF; Fraga MF
    Epigenetics; 2011 Jul; 6(7):870-4. PubMed ID: 21613817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.